Group 1 - The company has announced the date and details for the 2025 Second Extraordinary General Meeting of Shareholders, which will be held on September 8, 2025, at 14:30 [4][8][13] - The voting methods for the meeting will include both on-site and online voting, with specific time slots for each [5][6][9] - The company has confirmed that all board members attended the board meeting where the report was approved, ensuring the accuracy and completeness of the information [1.3][20] Group 2 - The company reported an increase in the number of distributors, with 51 new distributors added and 15 exiting, resulting in a total of 479 distributors by the end of the reporting period [27] - The company plans to purchase Directors and Officers Liability Insurance to enhance its risk management framework, with a compensation limit of up to 50 million RMB and an annual premium not exceeding 300,000 RMB [38][39] - The board of directors and the supervisory board have both approved the half-year report and the proposal for purchasing the liability insurance, which will be submitted for shareholder approval [22][30][32]

Core Viewpoint - The company has released its 2025 semi-annual report, ensuring the accuracy and completeness of the information provided, and has outlined its financial performance and future plans [1][4][5]. Group 1: Company Overview - The company is known as Tianjin Yao Daren Tang Group Co., Ltd., with the stock code 600329 [4]. - The report is unaudited and emphasizes the importance of reviewing the full semi-annual report for a comprehensive understanding of the company's performance [2][1]. Group 2: Financial Data - The company raised a total of RMB 836.08 million through a non-public offering of shares, with a net amount of RMB 814.34 million after deducting fees [24]. - As of June 30, 2025, the company has utilized RMB 669.88 million for investment projects and has a remaining balance of RMB 57.21 million in its fundraising account [24]. Group 3: Important Resolutions - The board approved the semi-annual report and a special report on the use of raised funds, with unanimous support from all attending directors [7][17]. - A proposal to purchase liability insurance for the company's directors, supervisors, and senior management was also approved, with an insurance limit of up to RMB 100 million [46]. Group 4: Fund Management - The company has established a management method for raised funds to ensure compliance with legal regulations and to protect investor rights [25]. - The company has permanently supplemented its working capital with RMB 150.14 million from surplus raised funds as of June 30, 2025 [37]. Group 5: Compliance and Reporting - The company has adhered to the regulations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and disclosure of raised funds [43].

证券代码：300627 证券简称：华测导航 公告编号：2025-075 上海华测导航技术股份有限公司 第四届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 上海华测导航技术股份有限公司（以下简称"公司"）第四届监事会第十八 次会议的通知于2025年7月28日以书面或电子邮件的形式发出，会议于2025年8月 合通讯方式召开。本次会议应出席监事3名，实际出席监事3名。本次会议由沈礼 伟先生主持，公司部分高级管理人员列席了本次会议。 本次会议的召开和表决程序符合《中华人民共和国公司法》 （以下简称"《公 经与会监事审议，以记名投票表决方式通过如下议案： 及其摘要》的议案。 经公司第四届监事会全体监事审议，一致认为公司2025年半年度报告及其摘 要的编制符合法律、行政法规和中国证监会的有关规定，报告内容真实、准确、 完整地反映了公司的实际情况，不存在虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）上的《2025 年半年度报告摘要》 （公告编号2025-07 ...

Core Viewpoint - The company intends to purchase directors, supervisors, and senior management liability insurance to enhance its risk management system and protect investor interests [1][2]. Group 1: Insurance Purchase Proposal - The company plans to buy liability insurance for all directors, supervisors, and senior management to mitigate operational risks [1]. - The proposal will be submitted directly to the shareholders' meeting for approval, as all directors and supervisors are considered interested parties and will abstain from voting [1]. Group 2: Authorization Matters - The shareholders' meeting will authorize the management to handle all matters related to the purchase of the liability insurance, including determining other insured parties, selecting insurance companies, and setting insurance terms [2]. - The authorization will remain valid until the end of the current board's term, allowing for renewal or reinsurance without further approval [2].

Core Viewpoint - Tianyu Biological Technology Co., Ltd. has announced the use of its own funds to pay for part of the fundraising investment project and will replace it with an equivalent amount of raised funds, ensuring the smooth implementation of the project without affecting the interests of shareholders [1][8][11]. Fundraising Basic Situation - The company raised a total of RMB 402.27 million by issuing 48.35 million shares at a price of RMB 8.32 per share, with a net amount of RMB 393.87 million after deducting issuance costs [1]. Fundraising Investment Project Situation - The company adjusted its fundraising usage plan due to the net amount being less than initially planned, with the project "Tianchang Longgang Red Cultural Tourism Scenic Area Engineering General Contracting Project" extended to be operational by December 2025 [3]. Reasons and Process for Using Own Funds - The company faced difficulties in directly using raised funds for certain payments, such as wages for migrant workers, which necessitated the use of its own funds initially, followed by a replacement with raised funds [5][6]. Impact on the Company - The decision to use self-funds for part of the project payments will not affect the normal implementation of the fundraising project and will not change the direction of the raised funds or harm the interests of shareholders [8][10]. Review Procedures and Opinions - The board of directors and the supervisory board have approved the use of self-funds and the subsequent replacement with raised funds, confirming that the decision aligns with the interests of the company and shareholders [9][10].

Core Viewpoint - The company plans to purchase liability insurance for its directors, supervisors, and senior management to enhance its risk management system and protect the interests of the company and its investors [1][2]. Group 1: Insurance Plan - The insurance contract will be negotiated based on market prices for subsequent renewals [1]. - The company intends to authorize its management to handle all matters related to the purchase of the liability insurance, including determining the insured parties, insurance company, coverage amount, and premium, as well as appointing insurance brokers [1]. Group 2: Approval Process - The proposal for purchasing the liability insurance was reviewed by the company's board and supervisory committee, with all relevant parties abstaining from voting due to conflict of interest [2]. - The supervisory committee supports the purchase, stating it will improve the company's risk management and governance environment, thereby protecting the rights of shareholders [2].

Meeting Overview - The sixth session of the 14th Supervisory Board meeting of Jiangsu Baoli International Investment Co., Ltd. was held on June 25, 2025, with all three supervisors present [1] - The meeting was conducted in accordance with the Company Law of the People's Republic of China and the company's articles of association [1] Voting Results - The meeting approved the proposal for the company to engage in commodity and foreign exchange hedging business, with a unanimous vote of 3 in favor, 0 against, and 0 abstentions [1] - The Supervisory Board believes that engaging in hedging business will help mitigate adverse impacts from price and exchange rate fluctuations on the company's operations, aligning with relevant regulations [1] Additional Proposals - A proposal for the company to purchase directors and officers liability insurance was also discussed, with all supervisors abstaining from voting, resulting in 0 votes for, 0 against, and 0 abstentions [2] - The Supervisory Board views this insurance as beneficial for enhancing the company's risk management system and protecting the rights of directors, supervisors, and senior management [2]

Group 1 - The core point of the announcement is the resolutions made during the fourth meeting of the fifteenth board of directors of China Baoan Group Co., Ltd, which includes discussions on director and supervisor allowances, purchasing liability insurance for directors and senior management, and the reappointment of the accounting firm [1][2][3][4]. Group 2 - The board proposed an annual allowance of RMB 240,000 for independent directors and RMB 180,000 for non-independent directors, while supervisors will receive RMB 120,000 annually [2]. - The company plans to purchase liability insurance for its directors, supervisors, and senior management with a coverage limit of RMB 100 million and an annual premium not exceeding RMB 500,000 [3]. - The board approved the reappointment of Zhongshun Zhonghuan Accounting Firm as the auditing institution for the 2025 financial report and internal control, with an audit fee of RMB 2 million [9][10][22]. Group 3 - The board proposed to change the director and adjust the members of the specialized committees, nominating Liu Zhihua as a candidate for non-independent director [5][25]. - The board meeting approved the proposal to hold the 2024 annual general meeting on June 30, 2025, to discuss various resolutions [6][28]. Group 4 - The company will conduct the annual general meeting with both on-site and online voting options, allowing shareholders to participate in the decision-making process [30][31][43]. - The registration date for shareholders to attend the meeting is set for June 25, 2025 [32].

Group 1 - The company will hold its second extraordinary general meeting of shareholders on May 26, 2025, at 15:00 in the company meeting room [1] - Shareholders registered by 15:00 on the day before the meeting are entitled to attend, and those unable to attend may appoint proxies [1][2] - The meeting will include voting through the Shanghai Stock Exchange's online voting system on the same day [1] Group 2 - The agenda includes the review of several proposals, including the signing of a Directors, Supervisors, and Senior Management Liability Insurance Agreement [2][3] - The company plans to continue purchasing liability insurance for its directors, supervisors, and senior management, with a premium of 500,000 yuan and a coverage limit of 50 million yuan [2][3] - The insurance will be effective for 12 months from the date of contract signing [2] Group 3 - The company proposes to amend certain provisions of its Articles of Association to enhance corporate governance [3] - The board has approved the proposal to elect three non-independent directors to fill vacancies due to resignations [4][5] - Candidates for non-independent directors include individuals with extensive experience in finance and management [6][7] Group 4 - The company also plans to elect two independent directors following the resignation of current independent directors [8][9] - The independent director candidates have backgrounds in finance, accounting, and law [10][11] Group 5 - The company intends to elect one supervisor to replace the chairman of the supervisory board who has resigned [12] - Candidates for the supervisory position have relevant experience in finance and management [13]

Group 1 - The company has proposed to purchase liability insurance for its directors, supervisors, and senior management to mitigate operational risks and protect their rights [57][58] - The insurance coverage limit is set at no more than 30 million RMB, with an annual premium not exceeding 250,000 RMB [58] - The proposal requires approval from the shareholders' meeting as the directors and supervisors are the insured parties and will abstain from voting [57][58] Group 2 - The company reported a net loss of 307.93 million RMB for the fiscal year 2024, with an unallocated profit of -272.11 million RMB as of December 31, 2024, exceeding one-third of the paid-in capital of 242.37 million RMB [60][61] - The loss is attributed to a significant decline in the market prices of lithium compounds and derivatives, impacting revenue and gross profit [61] - The company has conducted impairment tests on various assets, leading to substantial impairment provisions, which have further affected the financial results [62] Group 3 - The company plans to cancel 1.17 million stock options that have expired and remain unexercised, which accounts for 0.48% of the total share capital [41][49] - This cancellation is in compliance with the relevant regulations and will not have a significant impact on the company's financial status or operational performance [49][50] - The decision has been approved by the board and the supervisory committee, ensuring that it does not harm the interests of shareholders [50] Group 4 - The company has announced a daily related transaction with its affiliate, Jing Shan Hua Xia Industrial Technology Co., Ltd., with an estimated total amount not exceeding 3 million RMB for leasing factory premises in 2025 [30][31] - This transaction has been approved by the board and does not require further shareholder approval as it does not constitute a major asset restructuring [30][31] - The pricing for the transaction is based on market rates, ensuring fairness and compliance with regulations [35][37] Group 5 - The company has undergone a change in accounting policies in accordance with the Ministry of Finance's new interpretations, which will not have a significant impact on its financial statements [51][55] - The changes are aimed at ensuring that the company's financial reporting remains accurate and compliant with the latest regulations [55]